A multicenter, prospective cohort study of pediatric pulmonary fever Qing granules for community-acquired pneumonia in children based on a realistic medical setting
- Conditions
- community-acquired pneumonia in children
- Registration Number
- ITMCTR2200006542
- Lead Sponsor
- Beijing Children's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Community-acquired pneumonia in children diagnosed as a Western medicine disease;
(2) TCM syndrome differentiation is heat evil pulmonary closure syndrome;
(3) Age 1-14 years (=14 years);
(4) Course of disease =5 days;
(5) The informed consent meets the requirements. Children aged =8 years shall sign the informed consent with their guardian
(1) Patients with central cyanosis, severe respiratory distress, food refusal or dehydration signs, and disturbance of consciousness (lethargy, coma, convulsion);
(2) Patients with nausea, vomiting, diarrhea and other gastrointestinal reactions;
(3) Complicated with other respiratory infectious diseases, immune system diseases, malignant tumors;
(4) Patients with liver and kidney dysfunction and severe hematopoietic system diseases;
(5) Allergic to the drug in this study or the investigator considers it inappropriate to enter this study
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical recovery time;
- Secondary Outcome Measures
Name Time Method